CymaBay Therapeutics, Inc. (CBAY) is primed for evolution with the beta value of 1.03 – The InvestChronicle

Posted on by

CymaBay Therapeutics, Inc. (CBAY) is priced at $1.80 after the most recent trading session. At the very opening of the session, the stock price was $1.83 and reached a high price of $1.9, prior to closing the session it reached the value of $1.82. The stock touched a low price of $1.8.

CymaBay Therapeutics, Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the companys stock is recorded $13.55 on 05/15/19, with the lowest value was $1.21 for the same time period, recorded on 03/18/20.

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stocks existing status and the future performance. Presently, CymaBay Therapeutics, Inc. shares are logging -86.68% during the 52-week period from high price, and 49.17% higher than the lowest price point for the same timeframe. The stocks price range for the 52-week period managed to maintain the performance between $1.21 and $13.55.

The companys shares, operating in the sector of healthcare managed to top a trading volume set approximately around 528432 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the CymaBay Therapeutics, Inc. (CBAY) recorded performance in the market was -7.14%, having the revenues showcasing -2.15% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 122.96M, as it employees total of 24 workers.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.7011, with a change in the price was noted +0.1800. In a similar fashion, CymaBay Therapeutics, Inc. posted a movement of +10.84% for the period of last 100 days, recording 1,546,513 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the companys financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders equity. The total Debt to Equity ratio for CBAY is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

Raw Stochastic average of CymaBay Therapeutics, Inc. in the period of last 50 days is set at 91.30%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 88.46%. In the last 20 days, the companys Stochastic %K was 94.64% and its Stochastic %D was recorded 92.16%.

Bearing in mind the latest performance of CymaBay Therapeutics, Inc., several moving trends are noted. Year-to-date Price performance of the companys stock appears to be encouraging, given the fact the metric is recording -7.14%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -59.91%, alongside a downfall of -85.79% for the period of the last 12 months. The shares increased approximately by 12.54% in the 7-day charts and went down by 15.92% in the period of the last 30 days. Common stock shares were lifted by -2.15% during last recorded quarter.

Read this article:

CymaBay Therapeutics, Inc. (CBAY) is primed for evolution with the beta value of 1.03 - The InvestChronicle

COVID 2.0: The deadly evolution of misinformation – Sky News Australia

Posted on by

Evidence is mounting that the killer coronavirus has already mutated into dozens of new strains, but the dire warnings of scientists appear to be falling, yet again, on the deaf ears of those coordinating the pandemic.Several studies have confirmed the mutation phenomenon is a reality for the Wuhan virus but the World Health Organization appears to be unwilling to draw conclusions from these early studies.The official line is still: there is no evidence that the virus has been changing.Viruses are incredibly complex, especially the novel variety, so caution is understandable.A virus is neither alive nor dead and it continues existing through a process of replication which inevitably becomes error-ridden.Those mistakes in genetic sequencing become mutations.This is a function of existence which is both unavoidable and the very reason species evolve.It is simply untrue to suggest that there is no evidence the virus has been changing and the WHOs stance has been puzzling to scientists who study viruses and understand how they evolve.According to epidemiologist Erik Volz at Imperial College London, all viruses mutate and COVID-19 is no exception.I think its a fact that there are two strains, he said.Its normal for viruses to undergo evolution when they are transmitted to a new host.University of Reading biomedical scientist Ian Jones reveals a virus mutates half a dozen times each time it replicates in its victims respiratory tract.There is plenty of evidence the virus is changing but the WHO is reluctant to accept this well-documented scientific fact.And why does it matter?Different strains can vastly change the direction of this pandemic. Strains can be more aggressive, contain a more potent viral load, as scientists describe it, and even target specific demographics more ferociously.All of which could have vast implications for isolation policies such as the effectiveness of herd immunity or the need for people with certain medical conditions to isolate for longer periods of time.Researchers in India believe they have discovered evidence of at least 10 different strains.National Institute of Biomedical Genomics researcher Partha Majumder believes the Wuhan virus started off as an ancestral O-type strain before splitting off into several other versions.That original strain, now dubbed SARS-CoV2, appeared to be a bolstered version of the old SARS virus which had muted to have better transmission rates.To live, a virus must propagate by infecting other animals, he wrote.A mutation usually disables the virus from transmitting itself.However, some mutations enable the virus to transmit more efficiently and infect more persons.Such mutant viruses increase the frequency of transmission and sometimes completely replace the original type of the virus. The SARS-CoV2 is doing just that."Concerningly one strain, A2a, accounted for nearly half of test samples making it the most dominant strain the Indian team encountered.As scientists from different fields begin to pool their experiences with the virus it is becoming clearer that specific demographics are more at risk to the mutated strains.Obesity and age appear to be the largest and most obvious risk factors, but it has emerged that at least some strains of the Wuhan virus are triggering stokes in people outside of those demographic confines.Researchers at the New England Journal of Medicine are probing the deaths of five coronavirus patients, all aged under 50, who suffered large vessel strokes in a two week period.Of the five, one patient died, one is in intensive care and three are in post-stroke recovery.The concern for researchers were the near-complete lack of symptoms for all individuals.It appears that one strain of the coronavirus targets large blood vessels in a manner similar to what happened with the first SARS outbreak.Moreover, large-vessel stroke was reported in association with the 2004 SARS-CoV-1 outbreak in Singapore, the researchers wrote.Coagulopathy and vascular endothelial dysfunction have been proposed as complications of Covid-19.3 The association between large-vessel stroke and Covid-19 in young patients requires further investigation.It is disappointing that senior health officials at the WHO have failed to address any of the above concerns.While the scientific community does not share consensus issuing absolutist statements suggesting the virus cannot mutate, or cannot be transmitted from person to person, is dangerous and could have very deadly consequences.As more is learned about the Wuhan virus the real experts must be brought into the conversation and our leaders must be cautious about taking advice from an organisation which has got so much wrong.

See original here:

COVID 2.0: The deadly evolution of misinformation - Sky News Australia

Genius Brands International, Inc. (GNUS) is primed for evolution with the beta value of 0.20 – The InvestChronicle

Posted on by

Lets start up with the current stock price of Genius Brands International, Inc. (GNUS), which is $0.32 to be very precise. The Stock rose vividly during the last session to $0.34 after opening rate of $0.31 while the lowest price it went was recorded $0.31 before closing at $0.30.

Genius Brands International, Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the companys stock is recorded $2.33 on 05/08/19, with the lowest value was $0.05 for the same time period, recorded on 03/12/20.

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stocks existing status and the future performance. Presently, Genius Brands International, Inc. shares are logging -86.27% during the 52-week period from high price, and 520.16% higher than the lowest price point for the same timeframe. The stocks price range for the 52-week period managed to maintain the performance between $0.05 and $2.33.

The companys shares, operating in the sector of services managed to top a trading volume set approximately around 1.61 million for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Genius Brands International, Inc. (GNUS) recorded performance in the market was 9.68%, having the revenues showcasing -7.23% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 8.68M, as it employees total of 19 workers.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.2823, with a change in the price was noted +0.0282. In a similar fashion, Genius Brands International, Inc. posted a movement of +9.42% for the period of last 100 days, recording 718,849 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the companys financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders equity. The total Debt to Equity ratio for GNUS is recording 0.60 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.34.

Raw Stochastic average of Genius Brands International, Inc. in the period of last 50 days is set at 69.25%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 75.63%. In the last 20 days, the companys Stochastic %K was 61.86% and its Stochastic %D was recorded 54.88%.

Considering, the past performance of Genius Brands International, Inc., multiple moving trends are noted. Year-to-date Price performance of the companys stock appears to be pessimistic, given the fact the metric is recording 9.68%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -56.37%, alongside a downfall of -84.66% for the period of the last 12 months. The shares increased approximately by 0.28% in the 7-day charts and went up by 14.03% in the period of the last 30 days. Common stock shares were lifted by -7.23% during last recorded quarter.

Here is the original post:

Genius Brands International, Inc. (GNUS) is primed for evolution with the beta value of 0.20 - The InvestChronicle

Omnicom Group Inc. (OMC) is primed for evolution with the beta value of 0.73 – The InvestChronicle

Posted on by

Omnicom Group Inc. (OMC) is priced at $55.87 after the most recent trading session. At the very opening of the session, the stock price was $56.02 and reached a high price of $56.32, prior to closing the session it reached the value of $57.03. The stock touched a low price of $55.01.

Omnicom Group Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the companys stock is recorded $85.05 on 07/16/19, with the lowest value was $46.37 for the same time period, recorded on 03/23/20.

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stocks existing status and the future performance. Presently, Omnicom Group Inc. shares are logging -34.31% during the 52-week period from high price, and 20.49% higher than the lowest price point for the same timeframe. The stocks price range for the 52-week period managed to maintain the performance between $46.37 and $85.05.

The companys shares, operating in the sector of services managed to top a trading volume set approximately around 851928 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Omnicom Group Inc. (OMC) recorded performance in the market was -29.61%, having the revenues showcasing -24.95% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 12.45B, as it employees total of 70000 workers.

During the last month, 3 analysts gave the Omnicom Group Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 6 analysts were recommending to HOLD this stock, 1 of them gave the stock UNDERWEIGHT rating, and 3 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 68.82, with a change in the price was noted -23.89. In a similar fashion, Omnicom Group Inc. posted a movement of -29.88% for the period of last 100 days, recording 2,415,393 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the companys financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders equity. The total Debt to Equity ratio for OMC is recording 1.85 at the time of this writing. In addition, long term Debt to Equity ratio is set at 1.62.

Raw Stochastic average of Omnicom Group Inc. in the period of last 50 days is set at 30.09%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 50.27%. In the last 20 days, the companys Stochastic %K was 66.23% and its Stochastic %D was recorded 74.33%.

Lets take a glance in the erstwhile performances of Omnicom Group Inc., multiple moving trends are noted. Year-to-date Price performance of the companys stock appears to be encouraging, given the fact the metric is recording -29.61%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -26.12%, alongside a downfall of -27.78% for the period of the last 12 months. The shares increased approximately by 9.37% in the 7-day charts and went up by 10.76% in the period of the last 30 days. Common stock shares were lifted by -24.95% during last recorded quarter.

View original post here:

Omnicom Group Inc. (OMC) is primed for evolution with the beta value of 0.73 - The InvestChronicle

Xenia Hotels & Resorts, Inc. (XHR) is primed for evolution with the beta value of 1.18 – The InvestChronicle

Posted on by

Lets start up with the current stock price of Xenia Hotels & Resorts, Inc. (XHR), which is $10.22 to be very precise. The Stock rose vividly during the last session to $10.51 after opening rate of $9.87 while the lowest price it went was recorded $9.87 before closing at $9.46.

Xenia Hotels & Resorts, Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the companys stock is recorded $23.33 on 05/06/19, with the lowest value was $6.28 for the same time period, recorded on 03/19/20.

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stocks existing status and the future performance. Presently, Xenia Hotels & Resorts, Inc. shares are logging -56.19% during the 52-week period from high price, and 62.74% higher than the lowest price point for the same timeframe. The stocks price range for the 52-week period managed to maintain the performance between $6.28 and $23.33.

The companys shares, operating in the sector of financial managed to top a trading volume set approximately around 1.08 million for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Xenia Hotels & Resorts, Inc. (XHR) recorded performance in the market was -52.71%, having the revenues showcasing -47.46% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 1.15B, as it employees total of 48 workers.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 15.98, with a change in the price was noted -10.57. In a similar fashion, Xenia Hotels & Resorts, Inc. posted a movement of -50.84% for the period of last 100 days, recording 900,517 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the companys financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders equity. The total Debt to Equity ratio for XHR is recording 0.74 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.74.

Raw Stochastic average of Xenia Hotels & Resorts, Inc. in the period of last 50 days is set at 30.05%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 83.97%. In the last 20 days, the companys Stochastic %K was 57.26% and its Stochastic %D was recorded 36.86%.

Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the companys stock appears to be encouraging, given the fact the metric is recording -52.71%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -51.03%, alongside a downfall of -52.79% for the period of the last 12 months. The shares increased approximately by 2.50% in the 7-day charts and went up by 24.48% in the period of the last 30 days. Common stock shares were lifted by -47.46% during last recorded quarter.

See original here:

Xenia Hotels & Resorts, Inc. (XHR) is primed for evolution with the beta value of 1.18 - The InvestChronicle

Ferro Corporation (FOE) is primed for evolution with the beta value of 1.82 – The InvestChronicle

Posted on by

Ferro Corporation (FOE) is priced at $10.48 after the most recent trading session. At the very opening of the session, the stock price was $10.23 and reached a high price of $10.73, prior to closing the session it reached the value of $9.78. The stock touched a low price of $10.2.

Ferro Corporation had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the companys stock is recorded $18.03 on 04/30/19, with the lowest value was $7.52 for the same time period, recorded on 04/03/20.

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stocks existing status and the future performance. Presently, Ferro Corporation shares are logging -41.89% during the 52-week period from high price, and 39.36% higher than the lowest price point for the same timeframe. The stocks price range for the 52-week period managed to maintain the performance between $7.52 and $18.03.

The companys shares, operating in the sector of basic materials managed to top a trading volume set approximately around 1.24 million for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Ferro Corporation (FOE) recorded performance in the market was -29.33%, having the revenues showcasing -25.88% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 860.23M, as it employees total of 5922 workers.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 12.36, with a change in the price was noted -3.99. In a similar fashion, Ferro Corporation posted a movement of -27.57% for the period of last 100 days, recording 864,183 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the companys financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders equity. The total Debt to Equity ratio for FOE is recording 2.24 at the time of this writing. In addition, long term Debt to Equity ratio is set at 2.22.

Raw Stochastic average of Ferro Corporation in the period of last 50 days is set at 39.78%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 92.07%. In the last 20 days, the companys Stochastic %K was 78.32% and its Stochastic %D was recorded 66.57%.

Lets take a glance in the erstwhile performances of Ferro Corporation, multiple moving trends are noted. Year-to-date Price performance of the companys stock appears to be encouraging, given the fact the metric is recording -29.33%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -8.87%, alongside a downfall of -41.35% for the period of the last 12 months. The shares increased approximately by 10.94% in the 7-day charts and went up by 17.36% in the period of the last 30 days. Common stock shares were lifted by -25.88% during last recorded quarter.

Here is the original post:

Ferro Corporation (FOE) is primed for evolution with the beta value of 1.82 - The InvestChronicle

Seelos Therapeutics, Inc. (SEEL) is primed for evolution with the beta value of 1.14 – The InvestChronicle

Posted on by

Lets start up with the current stock price of Seelos Therapeutics, Inc. (SEEL), which is $0.59 to be very precise. The Stock rose vividly during the last session to $0.61 after opening rate of $0.54 while the lowest price it went was recorded $0.54 before closing at $0.53.

Seelos Therapeutics, Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the companys stock is recorded $3.06 on 04/30/19, with the lowest value was $0.42 for the same time period, recorded on 04/02/20.

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stocks existing status and the future performance. Presently, Seelos Therapeutics, Inc. shares are logging -80.67% during the 52-week period from high price, and 41.00% higher than the lowest price point for the same timeframe. The stocks price range for the 52-week period managed to maintain the performance between $0.42 and $3.06.

The companys shares, operating in the sector of healthcare managed to top a trading volume set approximately around 1.32 million for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Seelos Therapeutics, Inc. (SEEL) recorded performance in the market was -55.86%, having the revenues showcasing -49.01% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 25.56M, as it employees total of 6 workers.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.9309, with a change in the price was noted -0.3505. In a similar fashion, Seelos Therapeutics, Inc. posted a movement of -37.21% for the period of last 100 days, recording 784,184 in trading volumes.

Raw Stochastic average of Seelos Therapeutics, Inc. in the period of last 50 days is set at 22.92%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 90.29%. In the last 20 days, the companys Stochastic %K was 83.13% and its Stochastic %D was recorded 72.72%.

Considering, the past performance of Seelos Therapeutics, Inc., multiple moving trends are noted. Year-to-date Price performance of the companys stock appears to be encouraging, given the fact the metric is recording -55.86%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -34.39%, alongside a downfall of -80.35% for the period of the last 12 months. The shares increased approximately by 1.40% in the 7-day charts and went up by 25.85% in the period of the last 30 days. Common stock shares were lifted by -49.01% during last recorded quarter.

Continue reading here:

Seelos Therapeutics, Inc. (SEEL) is primed for evolution with the beta value of 1.14 - The InvestChronicle

Nobody coming to Henry Co. – News – Galva News

Posted on by

No visitors allowed in the area at least for now. So whats the director of the Henry County Tourism Bureau, whose job it is to entice people to the area, supposed to do?

Cheryl Osborne, executive director of the Henry County Tourism Bureau, described her current job as more maintenance than promoter.

The state of Illinois has frozen funds and grants that would have gone for advertising.

We would have had a campaign running, said Osborne, who took over the position almost three years ago.

The campaign would have included paid advertising outside of the area, from Peoria and the Quad Cities to as far north as Chicago, and promoted the area's springtime outdoor activities.

As of April 1, only essential spending through the end of the fiscal year in June, enough to keep the lights on, is being done.

But that doesn't mean Osborn doesn't still has plenty to do.

As far as spending goes, that doesnt mean I am not promoting Henry County, she said.

Ive still been promoting, but Im not pushing come see us.

Instead, Osborne said she is promoting the area in appropriate ways that would remind people about area events once the ban has been lifted. Its more like, Keep us in mind when they can travel.

The tourism bureaus website, visithenrycountry.com is still up and running. Osborn said she has added links to keep people updated about COVID-19. In addition, the website is posting information about already scheduled events that may be postponed, rescheduled, modified or cancelled.

Over the weekend, the annual Geneseo Art Walk went virtual. People could log on and take a virtual tour through the works of both amateur and professional artists. Other spring events, such as Galvas Freedom Fest, scheduled for the fourth of July, have been postponed. Bishop Hills Abba Salute Concert, originally planned for May 31, has been cancelled with hopes that it can be rescheduled. And Andovers 185 Anniversary event has been postponed until next year, making it the 186th Anniversary.

All of those activities generate traffic for local business which leads to tax revenue for the county and its municipalities which includes the tourism office. Without those extra activities, that local money doesn't get circulated and government budgets are diminished.

Osborn has recently started a social media page called Henry County Strong for county residents to share the latest news, updates, important information and resources.

The idea is to help our businesses and provide support and morale so when were ready for tourism, our businesses are supported at that time, she said.

The tourism bureau is also working with the Illinois Council of Convention and Visitors Bureaus on a plan for the aftermath of this unprecedented pandemic.

Were all working on a recovery plan, Osborn said. Once this is lifted and people are encouraged to travel more, How are we going to approach the recovery plan?

For now, Osborne sees the job of the tourism bureau as that of informational support and assistance.

Tourism is going to be a part of the recovery.

More:

Nobody coming to Henry Co. - News - Galva News

Conservatism in the crisis – The Economist

Posted on by

May 2nd 2020

FOLLOWING THE strangely tidy conclusion to their presidential primary, the Democrats are marching in lockstep. This week Senator Kirsten Gillibrand, queen of the #MeToo movement, dismissed an allegation of sexual assault against Joe Biden on the basis that the former vice-president had denied it. Al Franken and Brett Kavanaugh would have been glad of the same treatment.

Meanwhile the Republicans appear to be trying to fill the role of feuding opposition their rivals have vacated. The only stiff resistance to the $3trn stimulus authorised by Congress came from their ultra-libertarian wing. One of its members, Congressman Thomas Massie, accuses his colleagues of abandoning conservative principles by tiding over Americas shuttered economy. It seems he was not mollified by Mitch McConnells more tactical small-governmentism, displayed in the Senate leaders opposition to bailing out stricken Democratic states. Larry Hogan, the pragmatic Republican governor of Maryland, called letting states go bankrupt complete nonsense. Meanwhile a former compadre of Mr Massie in the House Freedom Caucus, Justin Amash, declared a plan to run for president for the Libertarians.

Another querulous Republican faction looks closer to the grain of the crisis. Led by some of the most interesting conservative thinkers, including Yuval Levin and Oren Cass, plus a handful of senators, it rejects Mr Massies market fundamentalism and takes a more flexible and positive view of government than most Republicans have since the 1970s. Its members, who include Trump-style populists and the remnants of a reform conservative movement that began in the doldrums of George W. Bushs presidency, want to turn the partys attention from economic freedom to socioeconomic outcomes, from corporations to workers. A pro-poor redesign of one stimulus bill by Senators Tom Cotton, Mitt Romney and Marco Rubio, all affiliated with this faction, was an indication of its growing alignment. Its members believe the crisis has validated their position and pushed it to the centre of politics.

Mr Rubio said as much in a searing critique of his partys economic libertarianism in the New York Times last week. He connected the damage it has done to some working-class communities, the loss of industrial capacity exposed by the crisis and the absence of adequate stockpiles of the medical supplies America no longer makes. All, he argued, are products of a misguided homage to economic efficiency, rooted in a hyperindividualistic ethos, that the coronavirus has shown to be self-defeating as well as immoral. To address these inadequacies, he would boost domestic production through a range of industrial and labour policies.

Mr Cass, who on May 5th will launch an impressive organisation of this dissident faction, called American Compass, would go further. A former policy director for Mr Romney, he describes the crisis similarly as an indictment of an economic piety that ignores many values that markets do not capture, including the well-being of American workers and development of future industries. Supply chains are much more than whoever is promising to make something more cheaply tomorrow, he says. In an influential book on labour-market reform, he has proposed a range of novel fixes, including wage subsidies and labour unions, and some familiar ones, including more aggressive deregulation than even Mr McConnell might consider feasible.

Politics does seem to be moving towards the dissidents. With the government standing between millions of Americans and ruin, hardly anyone, maybe not even Mr Massie, will propose starving the beast for a bit. The crisis is also likely to slow and, in specific industries such as health care, reverse globalisation. Yet the Republican quarrelling and rise of the dissidents are mainly a response to the equally disorientating reality of Donald Trump.

The presidents lack of attachment to any Republican faction has encouraged all to claim to be the animating spirit of his revolution. The Freedom Caucus claim him for their pugnacious anti-establishmentarianism. The small-government establishment notes that his only big legislative achievement was the tax reform it designed. The dissidents claim more convincingly to be offering solutions to the working-class grievances Mr Trump highlighted on the trail, even though he has since jettisoned them.

This may explain why their programme seems more political than the cerebral Mr Cass would care to admit. There is a rational and, given his focus on strengthening institutions, conservative case for his proposed labour-market reforms. The same cannot be said for the immigration curbs and laissez-faire attitude towards climate change he also advocates. Both look like pandering.

That is forgivable to a degree. Even critics of Mr Rubio and Mr Cass should recognise that their proposals are the most direct answer to the presidents ethno-nationalism available. Going back to the hoary question of whether his working-class fans were incited more by economic or by racial anxiety, Mr Trumps behaviour suggests he thinks it was the latter; Mr Rubio et al refuse to accept that.

The irony of this is that they have fashioned a virtuous Trumpian agenda that has little or no chance of being promulgated under Mr Trump. No more are the libertarians or small-government pharisees or pragmatists like Mr Hogan hopeful of influencing his scattergun administration. All are wrestling to claim the post-Trump future of their partywhich leads to two further conclusions.

First, that future will be determined not by ineluctable socioeconomic forces but by whoever wins the partys next presidential nomination. The Democrats embrace of fiscal rectitude in the 1990s now looks inevitable. But had Bill Clinton not scrambled to a second-place finish in New Hampshire, it would not have happened. Second, the fact that Republicans are feuding only six months from a general election suggests that many of them believe their post-Trump future may not be far off.

This article appeared in the United States section of the print edition under the headline "Conservatism in the crisis"

Link:

Conservatism in the crisis - The Economist

Advising Presidents: The Importance Of Maurice Greenberg – The National Interest

Posted on by

COTEMPORARY U.S. foreign policy challenges echo those that emerged in the immediate aftermath of the Cold War. From 1989 to 1994, with the dawn of a New World Order, the United States began a protracted process of bringing China and Russia into a more productive engagement with the West. It was predicated on the belief that economic policy shapes political systems and that free trade is one way to demonstrate the poverty of central planning. The legacy of that era continues today, with China better off thanks to free trade and Russia worse off due to its entrenched resistance to capitalism.

Clear-eyed statements of the challenge from that era remain valuable, and merit attention. A bracing starting point is the January 1989 Foreign Affairs article American Foreign Policy: The Bush Agenda by former President Richard M. Nixon, primarily addressing post-Soviet Russia. One of the most astute statesmen on the modern world stage, Nixon devoted most of his post-presidential years to international affairs, writing prolifically and engaging with leaders worldwide, urgently during this period.

Nixons chief interlocutors included a contemporary international business executive, Maurice R. (Hank) Greenberg, as immersed in international commerce as Nixon was in geopolitical strategy. Working with trailblazing investments in China begun in 1919 by his mentor, C.V. Starr, Greenberg became prominent for founding, in 1968, what he would lead to become the worlds largest commercial insurance company: American International Group (AIG).

For many years, the two maintained a vibrant correspondence on international affairs. That correspondence, along with related exchanges Greenberg conducted with other presidents and officials, illuminates contemporary challenges and potential solutions. It remains valuable for anyone interested in the sources and conduct of American foreign policy.

Greenberg and Nixon shared much in common, though from different perspectives: Nixon, the president and public servant; Greenberg, the global business executive who made U.S. foreign policy his and AIGs business. They were both internationalists, realists, and pragmatists. Nixon was a contemplative thinker, Greenberg a quick study. Patriots to the core, both leaders influenced governments and businesses around the world.

Greenbergs position at AIG gave him uniquely valuable insights into global affairs and incentives to promote free trade as well as the rule of law. The company had major operations across the world, and Greenberg engaged directly with heads of state and senior officials. This was essential to protect the interests of both AIG and its client base of large international corporations, including the United States most visible multinationals.

During his tenure, Greenberg maintained close working relationships with all U.S. presidents, memorialized in substantial correspondence. President Jimmy Carter expressed his gratitude for Greenbergs support of his effort to grant most-favored-nation (MFN) trading status to Chinawhile both recognized that their views on many other matters of political and economic philosophy differed considerably. Greenberg shared more philosophically with President Ronald Reagan, who once in a letter to Greenberg aptly called Nixon a great American hero.

As vice president, George Herbert Walker Bush wrote to Greenberg, congratulating him on becoming chairman of the U.S.-asean Council for Business, stressing his personal commitment to strong economic relations with South East Asian countries. Greenbergs correspondence with President Bill Clinton included many substantive letters, revealing both clear views and open minds. The younger George Bush, when president, wrote Greenberg to affirm their shared commitments to core principles that remain a national priority: tax relief, fiscal restraint, and less regulation.

Few business executives had the exposure and experience Greenberg enjoyed, making him a worthy correspondent of the Oval Office. On the subjects of China and Russia, the correspondence is valuable reading on two levelssubstance for the savvy strategic thinking, especially on free trade and economic policy; style for the urbane, patriotic, statesmen-like argumentation. On substantive matters, two subjects stand out in Greenbergs presidential correspondence: adamant support for MFN status with China, including through the aftermath of 1989s Tiananmen Square crackdown, as well as support for private economic intervention in Russia after the collapse of the Soviet Union.

THE FRIENDSHIP between Nixon and Greenberg dated to their successful joint efforts, along with Henry Kissinger, in the revival of China-U.S. diplomatic relations in 1974 and economic exchange thereafter. For the next fifteen years, the two nations enjoyed increasing interaction in many spheres, economic, cultural, and diplomatic. The American trio believed such exchanges to be in the national interest. They held to those beliefs despite domestic convulsions in China.

In early summer 1989, demonstrators protested in Beijings Tiananmen Square, seeking freedom and democracy. On June 4, 1989, the Chinese government responded by massacring hundreds of the protestors and jailing tens of thousands, stoking worldwide howls of protest. In the United States, President George H.W. Bush issued executive orders halting arms shipments and high-level diplomatic engagement; the House proposed heavy economic and trade sanctions and suspended funding for a variety of U.S.-Chinese programs.

Greenberg, Kissinger, and Nixon led informal back channel diplomacy to work through the crisis. Their correspondence captured their thinking, which would ultimately inform U.S. policy. On November 17, 1989 Greenberg wrote to Kissinger, sharing highlights of his recent visit with Chinas top leaders.

I dont have to repeat for you the discussions with regard to Tiananmen Square and the attitudes in the U.S. to those events. I was blunt in my discussions in Shanghai as you were in Beijing and I was in the talks that I had. The other side of that issue is the belief on the part of Chinese leadership that they were confronted with an incipient revolution.

Moreover, as we were told repeatedly, the Chinese will not bow to pressure, never have, that simply increases their resistance and furthermore the differences in culture between our country and theirs is repeatedly pointed out as well as the original understanding when relations were reinstituted that we would not interfere in their internal affairs.

One of the purposes of the America China Society has been to maintain a continuity of bipartisan foreign policy towards China, and I would hope that the Society expresses its grave concern to the Administration with respect to pending legislation dealing with sanctions.

[S]anctions have not proven to be a successful foreign policy tool. In this instance, the application of sanctions would set back China-U.S. relations for some time. We can have more influence by maintaining relations than by freezing them. I would also suggest that it is not in our national interest, regardless of how we feel about what occurred within China.

I also believe that it is not in our national interest with respect to foreign policy in Asia and indeed the world (given the changes taking place in the Soviet Union and Eastern Europe) for us to reduce our relationships with China from where they were before Tiananmen Square.

Congress was moving on legislation that would impose punishing sanctions on China. In a letter to Nixon on November 27, 1989, Greenberg explained his opposition to these pending bills. The context was a report on two trips Greenberg had taken to China in the prior two months. On the first, he met with Zhu Rongji, then mayor of Shanghai, for a session of the International Business Advisory Council. Greenberg reported:

The session in Shanghai covered how Shanghais economic development could be aided and/or assisted by foreign business. I was very candid with Mayor Zhu, as you were the Chinese leadership, in expressing the outrage which was felt universally over the tragic events in June. I also explained that foreign capital is directed where it feels secure, where an adequate return on equity is assured, and where laws and regulations are in place and not subject to change at whim. In addition, I cautioned against Central planning in that it discourages foreign investment with the concomitant increase in bureaucracy and inefficiency.

Greenberg turned to his second trip of that quarter, to Beijing, where he met with the countrys top officials, including President Yang Shangkun and Premier Li Pen. He shared with Nixon the following impressions, starting with the personal: he described Secretary General Jiang Zemin as forthright, knowledgeable, international in his outlook and, I believe, a person with whom we can do business. On policy, the topic of sanctions, Greenberg wrote:

I share your view that sanctions at this moment are wrongit is not in our national interest. Japan is gaining strength economically all the time and is exerting greater influence throughout Asia, making U.S.-China relations all the more important. The changes taking place in the Soviet Union and the uncertainness connected therewith, as well as Eastern Europe, reinforce the need to maintain a growing strategic relationship with China. Events in Europe, however, should not detract us from our interest in Asia

The bill on sanctions being passed by Congress will obviously be harmful to U.S.-China relations. I personally hope that there might be sufficient amendments to this bill that would permit the President to veto it. President Bush has a keen understanding of China and has tried to contain the damage. I believe that vetoing it is in our National interest, and hence, would not result in domestic political repercussions for the President that would have any lasting damage.

See more here:

Advising Presidents: The Importance Of Maurice Greenberg - The National Interest

Florida TMS Clinic Offering Copay Waiver for Those Suffering from Depression and Anxiety Affected by COVID-19 – MENAFN.COM

Posted on by

(MENAFN - GetNews)

Wesley Chapel, FL - Florida TMS Clinic boasts of a team of professionals that provide guidance to patients who come into their clinic with mental health conditions like depression. The doctors at Florida TMS Clinic understand that there is no one way to tackle this problem and this is why each patient that comes into their clinic is offered an individualized treatment approach, one that focuses on their specific needs and helps them work through their problems.

As a facility that focuses on the overall health and wellness of its patients, Florida TMS Clinic is proud to announce that it has waived copay for all patients that have been financially affected by the global pandemic caused by the novel coronavirus.

During the pandemic, Florida TMS Clinic will also be keeping its offices open to attend to the needs of patients who require help to get through the difficult times brought on by the global pandemic. While keeping its clinic open, Florida TMS Clinic focuses on the safety and well-being of patients and this is why their clinic has put in place certain measures aimed at improving biosafety.

As part of the measures put in place to help the members of its community during these hard times, Florida TMS Clinic is proud to also announce the opening of a second treatment room that will help to eliminate the waiting time, assuring patients of total compliance with the social distancing recommendation by the government and health bodies.

Putting in place plans to facilitate patients that will be coming into their clinic, Florida TMS Clinic has a lobby but will be implementing the no 'waiting room policy, which makes compliance with social distancing even more realistic while also following the CDC-recommended sterilization procedures to ensure all-around safety.

Patients coming into the clinic who are interested in learning more about the measures put in place are invited to visit the depression and anxiety treatment clinic's webpage at https://www.floridatmsclinic.com/COVID-19 .

As part of these measures, Florida TMS Clinic will also adopt the use of comprehensive screening and temperature checks while helping patients to get through these difficult times.

Further assuring the best attention, the spokesperson for the clinic said, 'At Florida TMS Clinic, we believe there is a better way to treat depression and other mood disorders. While medications and psychotherapy are often necessary, many individuals don't benefit from these methods of treatment or can't tolerate the side effects of medications. We're passionate about what we do, and take great pride in transforming the lives of our patients. Transcranial magnetic stimulation (TMS) is the most technologically advanced form of treatment for depression and anxiety. Our patients become our extended family. You will never be just another patient from the moment you walk through our door until long-after receiving TMS therapy.

Florida TMS Clinic remains committed to helping patients go through these trying times. Interested patients can check out the clinic's website at https://www.floridatmsclinic.com/ for the latest information.

Florida TMS Clinic is located at 26843 Tanic Drive, Ste 101, Wesley Chapel, FL 33544. Contact their team via phone at 813-867-2378 or send online inquiries via email to . For additional information regarding their services, visit the clinic's website.

Media Contact Company Name: FLORIDA TMS CLINIC Contact Person: Khaled Bowarshi, M.D. Email: Send Email Phone: 813-867-2378 Address: 26843 Tanic Drive, STE 101 City: Wesley Chapel State: FL Country: United States Website: https://www.floridatmsclinic.com/

MENAFN0105202000703268ID1100102041

Here is the original post:

Florida TMS Clinic Offering Copay Waiver for Those Suffering from Depression and Anxiety Affected by COVID-19 - MENAFN.COM

Posted in Tms

Pokmon GOs Elite TMs Arrive And Shake Up The Meta Movesets – TheGamer

Posted on by

Without exaggeration, the addition of Elite TMs to Pokmon GO is one of the most important changes in the history of the game. It will shake up how players aim to round out their collections and maximize the power of their teams. This new feature allows players to choose moves from both the regular TM list and Legacy moves, those that Pokmon were only able to learn naturally but are not longer available, and those from rare Community Day or Raid events.

This is a major game-changer for several reasons. From a practical standpoint, players will be able to take a far more relaxed approach to playing the game. No longer will players stress about putting in the grind on a special event day to possibly find a specific Pokmon with a specific move set. From a competitive standpoint, this is also going to have a major impact as well; rare moves are now more common, and the meta may see a slow shift as a result.

To be clear, this new feature is not exactly a free-for-all on every Pokmon. It looks like players are only going to get one Elite TM, for now. Hopefully there are more coming later, but for now players will have to consider carefully who to use their Elite TM on.

The obvious choice might be a strong, meta-defining Pokmon who has been unfortunate enough to have a terrible set of moves.The followingwould benefit most from having access to these specific abilities:

None of these moves should come as a surprise when considering the current meta of Raids and League Battles. Lapras runs wild in these places and could benefit immensely from any of the listed moves. Right now, a well-stated Lapras may be able to use Water Gun, but this pales in comparison to its ideal options.

RELATED:Pokmon GO Battle League Is Fun, But Shouldnt Be Mandatory

As for the rest of the moves, we are likely to see a fair bit of homogenization among Raids and Battle Leagues as players use their Elite TMsfor most of the moves listed above. Eventually we might see new Pokmon come in to counter these popular choices, but that would be a slow process since what the Elite TM effectively does is provide each player with a bit of perfection. Perfection in rounding out what may be a weak spot on their team, and perfection in terms of the current meta (which cannot quickly shift since Elite TMs will be limited.)

For now, players really need to take a good, long think about how best to use their Elite TMs, and not rush into wasting it on a Pokmon that they may regret choosing.

Source: heavy.com

NEXT:Epic Games Announces $2 Million Fortnite Invitational

Say Bye Bye To Tarantulas In Animal Crossing (For Now)

The Fantastic, Science-Fiction, and Horror are Patricios go-to genres for literature, film, and gaming. Dead by Daylight is his daily bread and butter as he writes for TheGamer. He teaches Spanish at McGill by day and writes next to his Staffy x Boxer rescue from the SPCA by night.Patricio graduated from the University of Alberta in 2006, 2012, and will have one more degree in hand by 2020. Innovation in game development, the economics of making games profitable, and the downward, decadent spiral of former great gaming companies fuels his soul to write daily. Will Blizzard Entertainment do something controversial often enough to keep this reference relevant? Patrick certainly believes they will.

View original post here:

Pokmon GOs Elite TMs Arrive And Shake Up The Meta Movesets - TheGamer

Posted in Tms

Global Toll Management System (TMS) Market With Positive Long-Term Growth Outlook 2020-2025 – Cole of Duty

Posted on by

The research repot of Toll Management System (TMS) Market presents the in the depth analysis on the basis of different parameters. The research report on Global Toll Management System (TMS) Market includes various segments. The study report presents the market overview as market size, revenue, share, forecast and market drivers. In addition, report offers an in depth analysis about the product scope and market opportunities and market risks for the participants. The report contains various subjects. Reports provides the description about the profile of the top manufacturers of the Global Toll Management System (TMS) Market. Also the information about market price, revenue, sales analysis and market Global market share from the base year 2019 to 2025 is provided.

This study covers following key players:TollPlusTelegraDonlenMike Albert Fleet SolutionsConduent TransportationRaytheonAitek-Aitek SpAGreen Tech ITSKENT ITS

Request a sample of this report @ https://www.orbisresearch.com/contacts/request-sample/4496805?utm_source=Manjiri

In this report, Market driving forces along with the market risks are presented. The market is segmented on the basis of application and market share & market growth rate by product type. Market breakdown data are shown on the regional and country level to present the sales and revenue of the market in the world. Competitive situation of the vendors is presented and analysed emphatically by landscape contrast. This section is important as it sheds light on the sales growth of various country level and regional level Global Toll Management System (TMS) Market. Furthermore, study report provides an analysis for the consumers to break the sales data at the country level across the globe.

In addition, the research report on Global Toll Management System (TMS) Market gives the in depth analysis of data source, appendix, research findings, customers, distributors, sales channel and conclusion of the market. Furthermore, reports presents come key drivers which contribute to the growth of the Global Toll Management System (TMS) Market. In addition, report provides some key reasons which can hamper the growth of the market during the forecast period. Thus study offers the growth estimation of the market on the basis of calculation by various segmentation and past and current data. This way research report can help the consumers to take the strategic initiatives for their growth in the Toll Management System (TMS) industry.

Access Complete Report @ https://www.orbisresearch.com/reports/index/global-toll-management-system-tms-market-growth-status-and-outlook-2020-2025?utm_source=Manjiri

Market segment by Type, the product can be split intoOn-premiseCloud Based

Market segment by Application, split intoHighwayUrbanOthers

Moreover, the study report presents the company profiles of players functioning in the market as well as the new entrants for the competition. Thus the competitive landscape provides the detailed information about the company with total revenue, Global presence, market potential and sales analysis of each player participating in the industry. Thus the report is beneficial for any client to expand the market growth in this industry by studying every segment covered in this research report.

For Enquiry before buying report @ https://www.orbisresearch.com/contacts/enquiry-before-buying/4496805?utm_source=Manjiri

Some TOC Points:1 Scope of the Report2 Executive Summary3 Global Toll Management System (TMS) by Company4 Toll Management System (TMS) by RegionsContinued

About Us:Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Us:Hector CostelloSenior Manager Client Engagements4144N Central Expressway,Suite 600, Dallas,Texas 75204, U.S.A.Phone No.: USA: +1 (972)-362-8199 | IND: +91 895 659 5155

Visit link:

Global Toll Management System (TMS) Market With Positive Long-Term Growth Outlook 2020-2025 - Cole of Duty

Posted in Tms

Treasury Management System (TMS) Market Growth Opportunities, Challenges, Key Companies, Drivers and Forecast to 2026 Cole Reports – Cole of Duty

Posted on by

BankSense

Global Treasury Management System (TMS) Market: Competitive Landscape

This section of the report lists various major manufacturers in the market. The competitive analysis helps the reader understand the strategies and collaborations that players focus on in order to survive in the market. The reader can identify the players fingerprints by knowing the companys total sales, the companys total price, and its production by company over the 2020-2026 forecast period.

Global Treasury Management System (TMS) Market: Regional Analysis

The report provides a thorough assessment of the growth and other aspects of the Treasury Management System (TMS) market in key regions, including the United States, Canada, Italy, Russia, China, Japan, Germany, and the United Kingdom United Kingdom, South Korea, France, Taiwan, Southeast Asia, Mexico, India and Brazil, etc. The main regions covered by the report are North America, Europe, the Asia-Pacific region and Latin America.

The Treasury Management System (TMS) market report was prepared after various factors determining regional growth, such as the economic, environmental, technological, social and political status of the region concerned, were observed and examined. The analysts examined sales, production, and manufacturer data for each region. This section analyzes sales and volume by region for the forecast period from 2020 to 2026. These analyzes help the reader understand the potential value of investments in a particular country / region.

We Offer up to 30% Discount @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=36233&utm_source=COD&utm_medium=007

Key Benefits for Stakeholders:

The report provides an in-depth analysis of the size of the Treasury Management System (TMS) world market, as well as recent trends and future estimates, in order to clarify the upcoming investment pockets.

The report provides data on key growth drivers, constraints and opportunities, as well as their impact assessment on the size of the Treasury Management System (TMS) market.

Porters 5 Strength Rating shows how effective buyers and suppliers are in the industry.

The quantitative analysis of the Treasury Management System (TMS) world industry from 2020 to 2026 is provided to determine the potential of the Treasury Management System (TMS) market.

This Treasury Management System (TMS) Market Report Answers To Your Following Questions:

Who are the main global players in this Treasury Management System (TMS) market? What is the profile of your company, its product information, its contact details?

What was the status of the global market? What was the capacity, the production value, the cost and the profit of the market?

What are the forecasts of the global industry taking into account the capacity, the production and the value of production? How high is the cost and profit estimate? What will be the market share, supply, and consumption? What about imports and export?

What is market chain analysis by upstream raw materials and downstream industry?

Get Complete Report @ https://www.verifiedmarketresearch.com/product/treasury-management-system-tms-market/?utm_source=COD&utm_medium=007

About us:

Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals and critical revenue decisions.

Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance use industrial techniques to collect and analyse data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

We study 14+ categories from Semiconductor & Electronics, Chemicals, Advanced Materials, Aerospace & Defence, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communication Technology, Software & Services, Information Security, Mining, Minerals & Metals, Building & construction, Agriculture industry and Medical Devices from over 100 countries.

Contact us:

Mr. Edwyne Fernandes

US: +1 (650)-781-4080UK: +44 (203)-411-9686APAC: +91 (902)-863-5784US Toll Free: +1 (800)-7821768

Email: [emailprotected]

Tags: Treasury Management System (TMS) Market Size, Treasury Management System (TMS) Market Trends, Treasury Management System (TMS) Market Growth, Treasury Management System (TMS) Market Forecast, Treasury Management System (TMS) Market Analysis

Read the original here:

Treasury Management System (TMS) Market Growth Opportunities, Challenges, Key Companies, Drivers and Forecast to 2026 Cole Reports - Cole of Duty

Posted in Tms

Treasury Management System (TMS) Market Overview, Top Companies, Region, Application and Global Forecast by 2026 – Latest Herald

Posted on by

Glory

Global Treasury Management System (TMS) Market Segmentation

This market was divided into types, applications and regions. The growth of each segment provides an accurate calculation and forecast of sales by type and application in terms of volume and value for the period between 2020 and 2026. This analysis can help you develop your business by targeting niche markets. Market share data are available at global and regional levels. The regions covered by the report are North America, Europe, the Asia-Pacific region, the Middle East, and Africa and Latin America. Research analysts understand the competitive forces and provide competitive analysis for each competitor separately.

To get Incredible Discounts on this Premium Report, Click Here @ https://www.marketresearchintellect.com/ask-for-discount/?rid=181900&utm_source=LHN&utm_medium=888

Treasury Management System (TMS) Market Region Coverage (Regional Production, Demand & Forecast by Countries etc.):

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

Some Notable Report Offerings:

-> We will give you an assessment of the extent to which the market acquire commercial characteristics along with examples or instances of information that helps your assessment.

-> We will also support to identify standard/customary terms and conditions such as discounts, warranties, inspection, buyer financing, and acceptance for the Treasury Management System (TMS) industry.

-> We will further help you in finding any price ranges, pricing issues, and determination of price fluctuation of products in Treasury Management System (TMS) industry.

-> Furthermore, we will help you to identify any crucial trends to predict Treasury Management System (TMS) market growth rate up to 2026.

-> Lastly, the analyzed report will predict the general tendency for supply and demand in the Treasury Management System (TMS) market.

Have Any Query? Ask Our Expert@ https://www.marketresearchintellect.com/need-customization/?rid=181900&utm_source=LHN&utm_medium=888

Table of Contents:

Study Coverage: It includes study objectives, years considered for the research study, growth rate and Treasury Management System (TMS) market size of type and application segments, key manufacturers covered, product scope, and highlights of segmental analysis.

Executive Summary: In this section, the report focuses on analysis of macroscopic indicators, market issues, drivers, and trends, competitive landscape, CAGR of the global Treasury Management System (TMS) market, and global production. Under the global production chapter, the authors of the report have included market pricing and trends, global capacity, global production, and global revenue forecasts.

Treasury Management System (TMS) Market Size by Manufacturer: Here, the report concentrates on revenue and production shares of manufacturers for all the years of the forecast period. It also focuses on price by manufacturer and expansion plans and mergers and acquisitions of companies.

Production by Region: It shows how the revenue and production in the global market are distributed among different regions. Each regional market is extensively studied here on the basis of import and export, key players, revenue, and production.

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage and more. These reports deliver an in-depth study of the market with industry analysis, market value for regions and countries and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Tags: Treasury Management System (TMS) Market Size, Treasury Management System (TMS) Market Growth, Treasury Management System (TMS) Market Forecast, Treasury Management System (TMS) Market Analysis

Our Trending Reports

Portable Electronic Laboratory Balance Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Portable Light Towers Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Here is the original post:

Treasury Management System (TMS) Market Overview, Top Companies, Region, Application and Global Forecast by 2026 - Latest Herald

Posted in Tms

Pokemon GO Elite TM: Best Moves to Teach Pokemon – Heavy.com

Posted on by

The Elite TM just added to Pokemon GO allows players to not only choose what Fast or Charged move they want their Pokemon to learn as opposed to regular TMs where the moves are learned at random, but it allows Pokemon to learn Legacy Moves moves that the Pokemon was able to learn naturally but are no longer able to as well as exclusive moves from Community Day events or special Raid periods.

As you can imagine, this opens up a world of possibilities. Now you no longer have to wait for that exclusive move to be available to get it. And some moves can be the difference between a Pokemon being a top tier threat and not.

Here are the best moves to teach Pokemon with the Pokemon GO Elite TM:

Swampert consistently runs high in the ranks of both Great League and Ultra League thanks to Hydro Cannons low energy cost and great damage allowing Swampert to not only put pressure on shields but erode the opponent. Normally a Community Day-exclusive move, Hydro Cannon will instantly turn your Swampert into a top tier threat. In fact, pretty much any of the starter Pokemon will see an instant upgrade by learning their Community Day-exclusive move, but Swampert is one of the best for this.

GamePress recommends pairing it with Mud Shot for PvP because of its high energy generation charging Hydro Pump more frequently and Water Gun for Raids because its the same type as Hydro Cannon and deals more damage overall than Mud Shot. For a second Charge Move, Earthquake provides a wide coverage and takes advantage of Same Type Attack Bonus (STAB) while Sludge Wave delivers a nasty surprise to grass-types not named Venusaur looking to take advantage of Swamperts double weakness to grass.

Dewgong ranks surprisingly high in the Great League (it currently ranks at #11 on Pvpoke) thanks to its bulk and its utility moveset, according to GamePress. However, thats only if you have access to both of its Legacy Moves Ice Shard and Icy Wind, which are much easier to obtain now that Elite TMs are a thing. Ice Shard has fantastic energy gain and Icy Wind not only has a low energy cost but lowers the attack of the opponent upon a hit.

Icy Wind should be paired with Water Pulse for more STAB coverage.

Lapras ranks high in both the Great and Ultra League, and while Water Gun is viable on its own Ice Shard has much better energy gain and plays well with both Surf and Ice Beam. Ice Beam is more flexible than Blizzard thanks to its lower energy requirement.

Dragon Pulse is another Legacy Move that can be obtained via an Elite TM. According to GamePress, while its slightly slower than Ice Beam it might be useful in dealing damage against Pokemon that resist water- and ice-type moves. Youd probably want to go for Ice Beam due to STAB, though.

Zapdos lagged behind Raikou in terms of power until it got access to Thundershock as a Legacy Move exclusive only to certain Raid Periods. Thundershock is a direct upgrade to Charge Beam in terms of damage and energy gain and plays well with Thunderbolt. Zapdos typing of electric and flying is one of the best in the game. It makes it resist ground-type moves along with several others, though it does make Zapdos weak to the ice-type attacks of Lapras and Dewgong who would normally be countered by electric-types. However, while Raikou doesnt resist as many types as Zapdos its still a king among electric-types thanks to its access to Wild Charge and Shadow Ball, and it doesnt need an Elite TM for those moves. Still, Zapdos definitely has a place in PvP as well as Raids.

Pair Thunderbolt with Drill Peck for shield-baiting and good STAB output, according to GamePress.

Venusaur shines in the Great League and Ultra League. While Roserade and Sceptile both have much higher DPS, Venusaur has more bulk which is very important in PvP. Frenzy Plant helps keep its relevance in the PvP sphere for the same reasons Hydro Cannon is so powerful, its got both great damage and great energy cost and efficiency.

Pair it with Vine Whip for more energy generation as well as Sludge Bomb for more STAB coverage, especially against fairy-types that might otherwise surprise you.

While Sceptile isnt as viable in PvP as Venusaur, its still one of the best grass-types in terms of raw DPS thanks to Frenzy Plant which makes it perfect for Raids against Bosses weak to grass.

Blaziken is a relatively strong threat for both fire- and fighting-type attackers. Blast Burn paired with the excellent Counter makes Blaziken one of the strongest counters to ice- and steel-type Raid Bosses. As for PvP, a secondary move of Stone Edge will give it a way to deal with flying-type counters.

That being said, Pvpoke suggests going with Blaze Kick instead of Blast Burn to better bait shields while still having Blaziken fill its role as a fire-type attacker.

Wing Attack is a direct upgrade to Air Slash and features slightly more energy gain than Fire Spin. Plus, flying- and fire-type moves have pretty similar coverage so they play well together. That being said, Fire Spin deals more damage over time.

As for Blast Burn, it makes for a viable substitute for Overheat. While Overheat deals much more damage, Blast Burn has lower energy cost and doesnt give Charizard the -2 debuff to attack.

Just like with Thundershock and Zapdos, Sky Attack is exclusive to Moltres caught during certain Raid Periods. Moltres with Sky Attack are cited by many as the best flying-type attackers in the game thanks to its low cost and great power.

Similarly with Charizard, go with Wing Attack if you want more energy gain and Fire Spin for more damage.

Mewtwo regularly ranks among the strongest attackers in both Raids and PvP, and both PsyStrike and Shadow Ball insure that. PsyStrike was exclusive to Mewtwo caught during certain Raid periods and is perfect for those that want psychic-type damage against fighting-types and poison-types. Shadow Ball is exclusive to EX Raids and gives Mewtwo some of the best neutral coverage in the game.

Pair Psystrike with Confusion for maximum DPS and pair Shadow Ball with Psycho Cut for more energy gain.

Metagross is just behind Dialga and Melmetal in terms of prominence as a steel-type attacker in Master League, but only with Meteor Mash. Dialga has more raw damage and Melmetal has more versatility in its toolset, but Metagross is a great choice too thanks to its Meteor Mash hitting hard and its access to Earthquake and Psychic.

Choose Earthquake for its coverage (especially against fire-types that might counter Metagross) and its sheer power. Psychic is also a neat choice; it doesnt have the coverage of Earthquake but it has a lower energy cost and hits neutral damage against things that would normally resist Meteor Mash, according to GamePress. Psychic also counters common threats to Metagross like Machamp.

Gardevoir has access to both Synchronoise and Psychic which are both pretty similar. If you have a Gardevoir with Psychic instead of Synchronoise, youd probably be just fine with it. However, Synchronoise is still faster especially with Charms low energy gain, according to Pvpoke.

Tyranitar is one of the best rock-type attackers. While it may not be as strong as Rampardos, it has much more bulk as well as access to the useful Crunch making it very viable in Master League despite its multiple weaknesses. Theres just one problem, it doesnt normally learn a rock-type Fast Move. But thanks to the Elite TM, you can give one its Community Day-exclusive move Smack Down.

Heres a recap of all the Pokemon that should learn Legacy or Exclusive moves from Elite TMs for your convenience:

Swampert Hydro CannonDewgong Ice Shard, Icy Wind & Aqua JetLapras Ice Shard, Ice Beam & Dragon PulseZapdos ThundershockVenusaur Frenzy PlantBlaziken Stone EdgeMewtwo Psystrike, Shadow BallMetagross Meteor MashGardevoir SynchronoiseTyranitar Smack DownMoltres Sky Attack

See also:

Follow this link:

Pokemon GO Elite TM: Best Moves to Teach Pokemon - Heavy.com

Posted in Tms

What Are The Different Types of Psoriasis? – HealthCentral.com

Posted on by

On this page:BasicsPlaque PsoriasisScalp PsoriasisNail PsoriasisGuttate PsoriasisInverse PsoriasisPustular PsoriasisErythrodermic PsoriasisPsoriatic Arthritis

With 125 million people in the world who have psoriasis, chances are you know someone who has the condition. But what you may not know is that there are several types of the chronic skin disease. They tend to get lumped in with the most common one: plaque psoriasis, which accounts for a whopping 80% of all cases. But there are six others that look, act, and may even be treated differently than the rest. Knowing which one you have can help you get better, faster.

Red, scaly, painful patches or bumps on your skin are the telltale signs of this inflammatory skin condition. It happens when your skin cells turn over at a way-too-fast rate (10 times faster than normal), causing a pile up of cells on the skins surface that form those angry, red patches, or plaques. Why this happens isnt so clear, but researchers believe psoriasis is caused by a mix of genetics, an overactive immune system, and triggers such as bacterial infection, skin trauma, smoking, medications, and obesity, just to name a few.

As we mentioned above, there are seven different types of psoriasis:

Theres also psoriatic arthritis, a combo of psoriasis and arthritis. Heres what you need to know about the causes and treatments for each one.

This is the type youre probably thinking of when someone mentions psoriasis. Its characterized by clearly demarcated, raised, red, scaly patches called plaques that appear most commonly on your elbows, knees, scalp, and back (but they can pop up anywhere on the body).

Because it accounts for 80% of all cases, plaque psoriasis tends to get the most press. Its the type addressed in most psoriasis drug commercials, and celebs including reality star Kim Kardashian and singer Cyndi Lauper have both been vocal about being plagued with plaques.

The cause for all cases of psoriasis stems from a combo of genetics, immune dysfunction, and triggers. People who have psoriasis are also more likely to have other inflammatory diseases such as Crohns disease, heart disease, or diabetes, suggesting some link between the underlying inflammation.

A study in Archives of Dermatology that looked at over 100,000 patients with psoriasis found those with severe psoriasis had a 46% greater chance of having diabetes than those without the skin disease.

There are several treatments that target plaques. Your physician will decide which one is right for you based on your general health, any underlying conditions, and the severity of your plaque psoriasis. Your options include:

Research suggests that biologics for psoriasis might help with those other inflammatory diseases linked to the skin condition, too. A study in Cardiovascular Research found that treating psoriasis with biologics helps reduce the plaque buildup in the arteries, which leads to heart attacks and strokes.

However, once your skin plaques disappear, youre not necessarily in the clear. Exposure to your triggers can bring on a new bout of plaque psoriasis. Only 10% of people are lucky enough to have whats called spontaneous remission, when your skin clears up forever and you never have a flare up again.

If youre scratching your head over an itchy scalp condition that wont clear up with a traditional dandruff shampoo, you may have scalp psoriasis. This type can go hand-in-hand with plaque psoriasis (see above), or even appear in those who dont have any history of the skin disorder at all.

Its often confused with dandruff, because, well, it itches and causes flakes, only these flakes are typically silvery-white and scaly. You might also have painful red scales or silver plaques on your head. In severe cases, scalp psoriasis appears as thickened, crusty patches of skin not only on the hairline, but also on the forehead, back of the neck and near the ears.

Unlike dandruff, scalp psoriasis doesnt come and go with the weather, hormonal fluctuations, or changes in hair products.The cause is the same as other types of psoriasis: an overactive immune system, genetics, and triggers such as stress and certain medications. But in this case, the plaques that show up may only show up on your scalp.

Mild cases can be nipped in the bud or improved with salicylic-, coal-tar-, or clobestasol propionate-containing (a topical steroid) shampoos. More severe cases may require systemic or biologic drugs, oral treatments, light therapy, or a combination of treatments. Unfortunately, you may lose some hair with some of these treatments, which is usually temporary.

If youve nailed it with psoriasis, then you know all too well that this type brings pitted, discolored, thickened, and even deformed fingernails and/or toenails. In severe cases, the nail plate can lift from the nail bed and you may see some gunk or even blood in between.

Of all the people who have some type of psoriasis, up to 50% will also have nail psoriasis. Like scalp psoriasis, it often comes along with plaque psoriasis, but it can also accompany other types or appear all on its own, too. Those with psoriatic arthritis will have an 80% chance of having nail psoriasis, too.

The same underlying causes as plaque psoriasis are at play here, too, revving up your skin cell production. Nails are considered part of the skin (theyre literally made up of skin cells), which is why they are also affected by the disease.

Typically, mild cases are treated with topical ointments rubbed into the nails such as:

More severe cases might require:

This type doesnt bring large plaques, but instead little red bumps smaller than a fingertip. You can wind up with hundreds of them scattered on your arms, legs, and torso.

About 10% of all psoriasis cases are the guttate type. You can have a mild case with just a few spots in one area, a moderate case that covers up to 10% of your body, or a severe breakout that leaves most, or even all, of your body covered in bumps.

This type often stems from a bacterial infection such as strep throat, an upper respiratory infection, or tonsillitis. There is also a genetic component. If a family member has had guttate psoriasis, youre more likely to get it, too.

Because guttate psoriasis is commonly triggered by infections, once you treat the infection, the psoriasis usually goes away, too. If the skin condition lingers, or you have a severe case, your physician may want to treat your symptoms with topical steroids and/or phototherapy, artificial UVB light that halts the inflammatory process.

This type affects fewer than 10% of people with psoriasis. Its called inverse psoriasis because it appears in unusual places such as the groin, armpits, bellybutton, genitals, under the breasts and behind the knees. Often, its accompanied by one of the other types of psoriasis listed here.

The same underlying culprits can lead to this type, only its brought on by sweat and friction. Thats why its commonly found in areas where there is skin-to-skin rubbing and moisture. Weight seems to be a factor, too. If youre overweight, youre more likely to have skin folds, prime spots for inverse psoriasis.

The gold standard is typically topical steroids and ointments in those vulnerable spots where moisture and friction are likely. If those dont work, phototherapy, and systemic treatments are an option.

As the name implies, this type causes pus-filled bumps. These white spots can appear anywhere on your body, but most commonly the hands and feet. The bumps come on suddenly and look infected, but theyre not.

The real danger here is damage to the skins barrier, the outermost protective layer of your skin. That means your skin cant retain water or nutrients, while also allowing bacteria and other irritants to get a fast pass into your body. As a result, in some cases, pustular psoriasis can be deadly, so make an appointment with your doctor asap, if you develop it.

There are a few sub-types of pustular psoriasis:

At the risk of sounding like a broken record, genes are to blame. But researchers have dug deeper and discovered a specific gene mutation that may be responsible for pustular psoriasis.

A study in the American Journal of Human Genetics IDd the gene AP1S3. If you have this particular genetic predisposition, the triggers for pustular psoriasis are often infection, stress, hormonal changes such as pregnancy, and exposure to chemicals. Also, certain drugs such as OTC pain relievers and anti-inflammatory drugs, penicillin, and some antidepressants such as lithium can trigger a flare. Stopping a course of steroids too fast can bring on a flare of pustular psoriasis, too.

Your doctor may prescribe a topical retinol or an immune-suppressing biologic such as Remicade (infliximab) to calm inflammation and stop the bumps. In severe cases, you may get a combo of a biologic and an oral immune-calming med such as Trexall (methotrexate) to get it under control.

The rarest of all psoriasis types, erythrodermic psoriasis affects only 2% of those with psoriasis. This type causes redness from head to toe, as if your skin has been burned. Even worse, its possible that your skin could peel off in sheets.

As with the pustular type, erythrodermic psoriasis severely compromises the skins protective barrier, so swift medical attention is a must. You can also develop fever, chills, swollen, painful joints, and rapid heart rate.

This type can be triggered by a bad sunburn, an infection, drug reaction, stopping a medication too abruptly, steroid use, stress, and alcoholism.

Your doctor will likely start with an immune suppressant. To soothe your sore skin, you may be prescribed topical steroids, itch-suppressing medications, or prescription pain treatments.

An estimated 30% of people with psoriasis also have or will develop psoriatic arthritis, or PsA, a chronic autoimmune condition that affects 2-3% of the population. While psoriasis affects the skin, psoriatic arthritis affects the joints and some parts of the body where ligaments and tendons are attached to the bone, particularly in the fingers, toes, wrists, knees and spine. The result is stiffness, swelling, pain and, if not caught early, irreversible damage, which is why early diagnosis and treatment are important.

PsA is an autoimmune disease. That means your immune system gets its messages mixed up and attacks healthy tissue, in this case, of your skin and joints. Youre also more likely to develop PsA if you have a family history of it (40% of people who have it also have a family member who has it, too), you already have psoriasis, and youre between the ages of 30 and 50.

If you have this condition, youll want to see a rheumatologist, a doctor who specializes in arthritis. Treatments can range OTC non-steroidal anti-inflammatory drugs (NSAIDs) such as Advil (ibuprofen) to disease-modifying antirheumatic drugs (DMARDs), including methotrexate, that work by slowing your immune system and your bodys inflammatory response. If those dont work, biologics may be considered.

Both can be itchy and cause shedding onto your hair, clothes and furniture. But the similarities stop there. Scalp psoriasis, like plaque psoriasis, is an autoimmune disease that is usually chronic and incurable. On the other hand, dandruff can go away on its own or be treated with a mild dandruff shampoo (if its caused by dry weather, for instance) and doesnt require medical attention.

Yes. In fact, keeping nails clean and trimmed and not biting them can help, and the cosmetic benefit can make you feel better about your nails. Be sure to tell your manicurist you have psoriasis because its easily mistaken with a fungal infection, which is contagious. One tip: Avoid long soaks. It robs your nails of moisture and that can make your nail psoriasis worse.

Around 85% of people develop skin psoriasis first or at the same time as psoriatic arthritis. Only about 15% get arthritis symptoms before the skin disease. Psoriasis is most likely to develop between 15 and 35 years old, while psoriatic arthritis shows up between ages 30 and 50.

For some people, guttate psoriasis, characterized by spotty, scaly lesions on arms, legs and torso, may come once and never return. It is commonly triggered by infections, like a common cold or strep throat. Once you treat it, it may be gone for good.

Go here to read the rest:

What Are The Different Types of Psoriasis? - HealthCentral.com

Visual Functions in Psoriatic Arthritis Sine-Psoriasis May Be Linked to Systemic Inflammation – Dermatology Advisor

Posted on by

Dry eye and subclinical abnormalities in visual functions in patients with psoriatic arthritis (PsA) sine-psoriasis may be related to systemic inflammation, according to study results published in the Journal of Clinical Medicine.

In this noninterventional, cross-sectional study, the disease activity of patients aged 18 to 65 years with diagnosed PsA and no evidence of skin psoriasis (n=40) was assessed by an experienced rheumatologist; a healthy control group (n=35) was also included in the study. All patients received a standard ophthalmology exam, which included best-corrected visual acuity, ocular surface disease index questionnaire, Schirmer test, and tear film breakup time (BUT). Standard automated perimetry, spectral-domain optical coherence tomography, and fundus perimetry scans were performed in all patients.

Researchers evaluated 80 and 70 eyes from patients in the PsA group (72.5% women; mean age, 5214 years) and the healthy control group (60% women; 48.713.8 years) , respectively. The best-corrected visual acuity of patients in the PsA group and the healthy control group were similar, and an abnormal ocular surface disease index (OSDI) was observed in 60% of patients with PsA. Prevalence of dry eye was significantly greater in the PsA group compared with the healthy control group (P <.0001). Approximately 75% of patients in the PsA group (n=30) were definitively diagnosed with dry eye (39.9% with BUT <10 sec; 23.4% with Schirmer 5 mm; 36.7% with both BUT <10 sec and Schirmer 5 mm).

Researchers indicated a positive correlation between OSDI and erythrocyte sedimentation rate (ESR; r=0.6; P <.001), In terms of the Schirmer test values, a negative correlation was observed between the scale of wetness and ESR (r=-0.43; P =.007). Results from standard automated perimetry indicated a higher mean deviation and pattern standard deviation in the PsA group compared with the healthy control group (P <.0001 and P =.005, respectively). In addition, ESR and C-reactive protein (CRP) showed a positive association with pattern standard deviation (r=0.3 and r=0.4; P =.04 and P =.01, respectively), while CRP was also correlated with mean deviation (r=-0.4; P =.01). Patients with PsA and the control participants demonstrated a similar visual field index (range, 98%-100%).

Assuming that relevant signs of systemic disease may be revealed as abnormalities occurring in the eye, a clinical evaluation of retinal morphology and function should be performed in order to detect subclinical damage of the visual system early, the researchers advised. In addition, careful ophthalmologic examination of patients with PsA sine-[psoriasis] may produce valuable clinical information on disease activity status. Using either [standard automated perimetry] or [fundus perimetry] and [optical coherence tomography] assessment could allow the detection of early changes in visual function even before clinically detectable retinopathy. These ancillary tests may serve as a useful monitoring tool over the entire course of the disease.

Reference

Chimenti MS, Triggianese P, Salandri G, et al. A multimodal eye assessment in psoriatic arthritis patients sine-psoriasis: evidence for a potential association with systemic inflammation. J Clin Med. 2020;9(3):E719.

This article originally appeared on Rheumatology Advisor

Read the original:

Visual Functions in Psoriatic Arthritis Sine-Psoriasis May Be Linked to Systemic Inflammation - Dermatology Advisor

Model Y Body-In-White May Shed Light On Tesla Glass Incidents – InsideEVs

Posted on by

The first time I reported an issue with glasses on Tesla vehicles was on January 6. Sergio Rodriguez's Model X had a waterfall in his dashboard. We later learned from Chad Hrencecin, from "The Electrified Garage," and also from George Catalin Marinescu, from "Doctor Tesla," that this was a common issue. New glass issues emerged in March. Surprisingly, the Tesla Model Y teardown shed some light on the causes of these problems.

Two recent videos come to the rescue about this subject. The first one, embedded above, had the goal of showing a naked body. Don't be naughty: it was the Model Y's body-in-white, or BIW, for short.

Munro showed the structures of the body, such as the shot guns, and talked about measures Tesla takes to make the Model Y a silent car, such as filling some of them with foam. The engineer also spoke about the lack of paint on the frunk bay, something we have already mentioned Toyota also does with the Etios, a cheap car sold in Brazil and India.

89 Photos

Again, Munro found welding splashes and was not very happy with the roof rack attachments. Part of the urethane that is used to glue the roof glass to the body had invaded the front attachment. That will make installing the roof rack a tough job. The engineer advises anyone willing to have one to order it from Tesla straight ahead: that's the only way to have it installed for sure.

This is when Munro shows that the urethane did not properly cure. That means this material was still raw, as if it had just been applied.

Could this be the reason for the rear glass of Ameya Amritwar's Model 3 to fly away from his car? It surely is related to the issue in Rodriguez's Model X. Urethane application seems to be something Tesla should give more attention to.

In the video right above, Munro has a cathartic moment showing he was right to push Ford to use modules for doors back in 1987. The video is worth watching just for that moment alone, by the way. Ford still does not use them, but that is not his problem anymore. He is just happy that Tesla does.

While showing the module, Munro mentions the stirrups and the compensation springs Tesla doors have because of the frameless windows its cars have.

Would these stirrups and springs be related to the glasses that are spontaneously breaking up, such as Balaji Simma's?

Perhaps these windows are shattering due to heat shocks, as some readers suggested. Anyway, what if they are related to the alignment of the doors? Or to the design of these modules? Or even to compensation springs that are too strong? We'll probably have to wait a little more to clarify this. If you have any information or related problem to report, get in touch with us.

See the original post:

Model Y Body-In-White May Shed Light On Tesla Glass Incidents - InsideEVs

Tesla Keeps Beating Expectations. Heres What Wall Street Is Saying About the Stock. – Barron’s

Posted on by

Text size

Teslas first-quarter earnings marked the third straight quarterly beat of Wall Street expectations. The results will nettle the bears and delight the bulls.

Heres what analysts are saying about the Wednesday evening report.

Investors were laser focused on the profitability picture of [Tesla] and Musk & Co. did not disappoint, Wedbush analyst Dan Ives said in a Thursday research report. Gross profit margins came in at 20.6%. Wall Street was looking for about 18%. Stronger profits is a sign of good manufacturing execution. Tesla recently started making cars in China, adding to its Fremont, Calif., capacity.

Ives rates shares the equivalent of Hold. He raised his price target from $425 to $600 and said his bull case for shares is $1,000. Ives is neutral, but there are still plenty of bearish analysts to hear from.

Dream lives on, RBC analyst Joe Spak wrote in his Thursday research report. He isnt buying into the dream though. He rates shares the equivalent of Sell, but he did increase his price target from $380 to $615 a share. Despite some positives, like profitability, he remains cautious. Bullishness is very high; we cant recommend adding believing that current price more than discounts positive arguments.

J.P. Morgan analyst Ryan Brinkman left his rating at the equivalent of Sell and his price target at $240. Our Underweight rating considers notable investment positives, including a highly differentiated business model, appealing product portfolio, and leading-edge technology, Brinkman said in a research report on Thursday. But he believes all the positives are more than offset by above-average execution risk and valuation that seems to be pricing in a lot.

New Street Research analyst Pierre Ferragu took a different tack than Brinkman. He increased his price target from $800 to $1,000 a share, the highest on Wall Street for now. He rates shares the equivalent of Buy.

The thing Ferragu focused on in his Thursday research report, like Ives, was profitability. Model Y already profitable with 5,000 units produced, he said. Model 3, S, X ex-subsidy gross margin up [2 percentage points] sequentially. The stronger profitability led him to increase profit margin estimates justifying the price-target increase.

In response to Covid-19 headwinds, [Tesla] withdrew 2020 guidance, noted Baird analyst Ben Kallo in a Thursday research report. That is one slight negative he saw in the earnings report. The company indicated it has the installed capacity to exceed the prior guidance of 500,000 vehicle deliveriesdespite downtimethough given uncertainty around production restart and supplier availability the company will not provide near-term net income or cash flow guidance.

Kallo, a long time Tesla bull, rates share the equivalent of Hold. He raised his price target Thursday from $525 to $700 a share.

The state of the supply chain is a good catch. Coordinating plant restarts around the country with different firms facing different mandates is no trivial issue. Restart headwinds and complexity are weighing on CEO Elon Musks nerves. Commenting on governmental stay at home orders he said: To say [people] cannot leave their house, and they will be arrested if they do, this is fascist. This is not democratic. This is not freedom.

The lack of guidance wasnt hurting shares in the morning. But the stock ended down 2.3% Thursday to $781.88 a share. Teslas nearly 90% year-to-date gains still far exceed comparable drops of the S&P 500 and Dow Jones Industrial Average.

Write to Al Root at allen.root@dowjones.com

Follow this link:

Tesla Keeps Beating Expectations. Heres What Wall Street Is Saying About the Stock. - Barron's